Trials / Unknown
UnknownNCT01430013
Trial of Endostar Combined With CHOPT for T Cell Lymphoma
Phase II Trial of Endostar Combined With CHOPT for T Cell Lymphoma
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the efficacy and safety of Endostar combined with CHOPT in the treatment of T cell lymphoma.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Endostar and CHOPT | Endostar 7.5mg/m2, for iv for continuous 14 days cyclophosphamide, pirarubicin, vincristine, teniposide, prednisone |
Timeline
- Start date
- 2011-06-01
- Primary completion
- 2015-11-01
- Completion
- 2015-12-01
- First posted
- 2011-09-07
- Last updated
- 2015-11-04
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT01430013. Inclusion in this directory is not an endorsement.